Jump to content

Paraneoplastic neurological syndromes: Difference between revisions

Paraneoplastic neurological syndromes (view source)

Revision as of 08:00, 21 July 2024

No change in size ,  21 July
no edit summary
VisualWikitext
(Created page with "<section begin="neurology" />Paraneoplastic neurological syndromes occur in 1 – 3% of patients with cancer. They often develop before the cancer diagnosis. They usually occur because the tumour expresses antigens which are structurally similar to antigens on neurons (molecular mimicry). Antineuronal antibodies are often present in the serum and CSF. It’s important to recognise these diseases because they can give earlier diagnosis of the...")
 
No edit summary
 
Line 1: Line 1:
[[Paraneoplastic syndrome|<section begin="neurology" />Paraneoplastic]] neurological syndromes occur in 1 – 3% of patients with cancer. They often develop before the cancer diagnosis. They usually occur because the tumour expresses antigens which are structurally similar to antigens on neurons (molecular mimicry). Antineuronal antibodies are often present in the serum and CSF.
<section begin="neurology" />[[Paraneoplastic syndrome|Paraneoplastic]] neurological syndromes occur in 1 – 3% of patients with cancer. They often develop before the cancer diagnosis. They usually occur because the tumour expresses antigens which are structurally similar to antigens on neurons (molecular mimicry). Antineuronal antibodies are often present in the serum and CSF.


It’s important to recognise these diseases because they can give earlier diagnosis of the tumour and because their prognosis is better the earlier the treatment is initiated. These conditions are usually treated by steroids and plasma exchange.
It’s important to recognise these diseases because they can give earlier diagnosis of the tumour and because their prognosis is better the earlier the treatment is initiated. These conditions are usually treated by steroids and plasma exchange.